Showing results (1-10 of 66) with videos related to
Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry|October 26, 2016
A new target for Parkinson's disease: Small molecule SERCA activator CDN1163 ameliorates dyskinesia in 6-OHDA-lesioned ratsRussell DahlBioorganic & Medicinal Chemistry|April 20, 2016
Cytoprotective small molecule modulators of endoplasmic reticulum stressSoumyabrata Munshi, Russell DahlBioorganic & Medicinal Chemistry Letters|April 1, 2018
A new target for Alzheimer's disease: A small molecule SERCA activator is neuroprotective in vitro and improves memory and cognition in APP/PS1 miceKatherine Krajnak, Russell DahlBioorganic & Medicinal Chemistry Letters|December 23, 2017
Small molecule SUMOylation activators are novel neuroprotective agentsKatherine Krajnak, Russell DahlBiochemical and Biophysical Research Communications|September 28, 2024
SERCA pump as a novel therapeutic target for treating neurodegenerative disordersRussell Dahl, Ilya BezprozvannyJournal of Pharmacological and Toxicological Methods|June 17, 2014
Alamar blue reagent interacts with cell-culture media giving different fluorescence over time: potential for false positivesSoumyabrata Munshi, Robert C Twining, Russell DahlChemical Biology & Drug Design|December 2, 2010
Design and NMR studies of cyclic peptides targeting the N-terminal domain of the protein tyrosine phosphatase YopHMarilisa Leone, Elisa Barile, Russell Dahl, et al.Organic Letters|December 30, 2009
Fully automated continuous flow synthesis of highly functionalized imidazo[1,2-a] heterocyclesAnanda Herath, Russell Dahl, Nicholas D P CosfordThe Journal of Organic Chemistry|August 9, 2008
Rapid multistep synthesis of 1,2,4-oxadiazoles in a single continuous microreactor sequenceDaniel Grant, Russell Dahl, Nicholas D P CosfordCell Reports|July 27, 2012
A gatekeeper residue for NEDD8-activating enzyme inhibition by MLN4924Julia I Toth, Li Yang, Russell Dahl, et al.Pageof 7